CD135 is a 130-160 kD type III tyrosine kinase receptor expressed on CD34+ hematopoietic stem cells, myelomonocytic progenitors, primitive B cell progenitors, and thymocytes. CD135 is also expressed on malignant hematopoietic cells including AML, ALL and CML-BC. CD135, also known as FMS-like tyrosine kinase-3, FLT3, STK-1, and Flk-2, is a growth factor receptor that binds the FLT3 ligand to promote the growth and differentiation of primitive hematopoietic cells. The intracytoplasmic domain of CD135 is modified by phosphorylation and has been shown to interact with Grb2, SOCS1, VAV1, and Shc.
AC710
From $95
AMG 925
From $85
AST 487
From $100
AT9283
From $90
AZD2932
From $85
CHIR-124
From $115
DCC-2036
From $90
Emavusertib
From $100
ENMD-2076
From $95
ENMD-2076 tartrate
From $80
Gilteritinib
From $90
Hypothemycin
From $2,435
KW 2449
From $95
Lestaurtinib
From $745
Linifanib (ABT-869)
From $90
LY2801653
From $95
MP-470
From $90
Nafamostat
From $80
Pacritinib
From $90
R406 free base
From $95
R788
From $90
R788 (disodium hexahydrate)
From $120
R788(prodrug of R406)
From $90